Minulet Contraindications

MINULET must not be used in women with any of the following conditions: Deep vein thrombosis (current or history).
Thromboembolism (current or history).
Cerebrovascular or coronary artery disease.
Thrombogenic valvulopathies.
Thrombogenic rhythm disorders.
Hereditary or acquired thrombophilias.
Headache with focal neurological symptoms, such as aura.
Diabetes with vascular involvement.
Uncontrolled hypertension.
Known or suspected carcinoma of the breast, or other known or suspected estrogen dependent neoplasia.
Hepatic adenomas or carcinomas, or active liver disease, as long as liver function has not returned to normal.
Undiagnosed vaginal bleeding.
Pancreatitis associated with severe hypertriglyceridemia (current or history).
Known or suspected pregnancy.
Hypersensitivity to any of the components of MINULET.
MINULET is contraindicated for concomitant use with the medicinal products containing ombitasvir, paritaprevir, ritonavir, and dasabuvir (see Hepatic neoplasia/liver disease/hepatitis C under Warnings and Interactions).
Reasons for Immediate Discontinuation of MINULET: The occurrence for the first time of migrainous headaches or the more frequent occurrence of unusually severe headaches.
Acute disturbances of vision, hearing, or other perceptual disorders.
First symptoms of thrombophlebitis or thromboembolism.
Development of jaundice (cholestasis), anicteric hepatitis, or generalized pruritus.
Increase in epileptic seizures.
Significant rise in blood pressure.
Pregnancy.